Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: ISAVUCONAZOLE, . Treffer: 22
2025
Wichmann, D; Hoenigl, M; Koehler, P; Koenig, C; Lund, F; Mang, S; Strauß, R; Weigand, MA; Hohmann, C; Kurzai, O; Heußel, C; Kochanek, M
Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline (AWMF 113-005).
Infection. 2025;
Doi: 10.1007/s15010-025-02572-2
Web of Science
PubMed
FullText
FullText_MUG
2024
Boyer, J; Hoenigl, M; Kriegl, L
Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?
Expert Rev Clin Pharmacol. 2024; 17(4):309-321
Doi: 10.1080/17512433.2024.2317293
Web of Science
PubMed
FullText
FullText_MUG
Jenks, JD; Hoenigl, M; Thompson, GR
Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis.
Contemp Clin Trials Commun. 2024; 39: 101310
Doi: 10.1016/j.conctc.2024.101310
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kriegl, L; Hatzl, S; Schilcher, G; Zollner-Schwetz, I; Boyer, J; Geiger, C; Hoenigl, M; Krause, R
Antifungals in Patients With Extracorporeal Membrane Oxygenation: Clinical Implications.
Open Forum Infect Dis. 2024; 11(6): ofae270
Doi: 10.1093/ofid/ofae270
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Serris, A; Rautemaa-Richardson, R; Laranjinha, J; Candoni, A; Garcia-Vidal, C; Alastruey-Izquierdo, A; Hammarström, H; Seidel, D; Styczynski, J; Sabino, R; Lamoth, F; Prattes, J; Warris, A; Porcher, R; Lanternier, F, , ESCAI, study, group, and, EFISG
European Study of Cerebral Aspergillosis treated with Isavuconazole: an EFISG study.
Clin Infect Dis. 2024;
Doi: 10.1093/cid/ciae371
Web of Science
PubMed
FullText
FullText_MUG
2023
Hatzl, S; Kriegl, L; Posch, F; Schilcher, G; Eller, P; Reisinger, A; Grinschgl, Y; Muhr, T; Meinitzer, A; Hoenigl, M; Krause, R
Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation.
J Antimicrob Chemother. 2023; 78(12):2902-2908
Doi: 10.1093/jac/dkad328
Web of Science
PubMed
FullText
FullText_MUG
Stemler, J; Mellinghoff, SC; Khodamoradi, Y; Sprute, R; Classen, AY; Zapke, SE; Hoenigl, M; Krause, R; Schmidt-Hieber, M; Heinz, WJ; Klein, M; Koehler, P; Liss, B; Koldehoff, M; Buhl, C; Penack, O; Maschmeyer, G; Schalk, E; Lass-Flörl, C; Karthaus, M; Ruhnke, M; Cornely, OA; Teschner, D
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
J Antimicrob Chemother. 2023; 78(8):1813-1826
Doi: 10.1093/jac/dkad143
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2022
Kriegl, L; Hatzl, S; Zurl, C; Reisinger, AC; Schilcher, G; Eller, P; Gringschl, Y; Muhr, T; Meinitzer, A; Prattes, J; Hoenigl, M; Krause, R
Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.
J Antimicrob Chemother. 2022; 77(9):2500-2505
Doi: 10.1093/jac/dkac196
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Enko, D; Zelzer, S; Herrmann, M; Krause, R; Meinitzer, A
Implementation of a Dual-Column Liquid Chromatography-Tandem Mass-Spectrometry Method for the Quantification of Isavuconazole in Clinical Practice
J LAB PHYS. 2021;
Doi: 10.1055/s-0041-1730755
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Nucci, M; Jenks, J; Thompson, GR; Hoenigl, M; Dos Santos, MC; Forghieri, F; Rico, JC; Bonuomo, V; López-Soria, L; Lass-Flörl, C; Candoni, A; Garcia-Vidal, C; Cattaneo, C; Buil, J; Rabagliati, R; Roiz, MP; Gudiol, C; Fracchiolla, N; Campos-Herrero, MI; Delia, M; Farina, F; Fortun, J; Nadali, G; Sastre, E; Colombo, AL; Pérez Nadales, E; Alastruey-Izquierdo, A; Pagano, L
Do high MICs predict the outcome in invasive fusariosis?
J Antimicrob Chemother. 2021; 76(4):1063-1069
Doi: 10.1093/jac/dkaa516
Web of Science
PubMed
FullText
FullText_MUG
2020
Koehler, P; Bassetti, M; Chakrabarti, A; Chen, SCA; Colombo, AL; Hoenigl, M; Klimko, N; Lass-Flörl, C; Oladele, RO; Vinh, DC; Zhu, LP; Böll, B; Brüggemann, R; Gangneux, JP; Perfect, JR; Patterson, TF; Persigehl, T; Meis, JF; Ostrosky-Zeichner, L; White, PL; Verweij, PE; Cornely, OA, ;European, Confederation, of, Medical, Mycology;International, Society, for, Human, Animal, Mycology;Asia, Fungal, Working, Group;INFOCUS, LATAM/ISHAM, Working, Group;ISHAM, Pan, Africa, Mycology, Working, Group;European, Society, for, Clinical, Microbiology;Infectious, Diseases, Fungal, Infection, Study, Group;ESCMID, Study, Group, for, Infections, in, Critically, Ill, Patients;Interregional, Association, of, Clinical, Microbiology, and, Antimicrobial, Chemotherapy;Medical, Mycology, Society, of, Nigeria;Medical, Mycology, Society, of, China, Medicine, Education, Association;Infectious, Diseases, Working, Party, of, the, German, Society, for, Haematology, and, Medical, Oncology;Association, of, Medical, Microbiology;Infectious, Disease, Canada
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
Lancet Infect Dis. 2021; 21(6):e149-e162
Doi: 10.1016/S1473-3099(20)30847-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zurl, C; Waller, M; Schwameis, F; Muhr, T; Bauer, N; Zollner-Schwetz, I; Valentin, T; Meinitzer, A; Ullrich, E; Wunsch, S; Hoenigl, M; Grinschgl, Y; Prattes, J; Oulhaj, A; Krause, R
Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations.
J Fungi (Basel). 2020; 6(2):
Doi: 10.3390/jof6020090
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Beyer, R; Spettel, K; Zeller, I; Lass-Flörl, C; Achleitner, D; Krause, R; Apfalter, P; Buzina, W; Strauss, J; Gregori, C; Schüller, C; Willinger, B
Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria.
MYCOSES. 2019; 62(4): 357-367.
Doi: 10.1111/myc.12892
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Cornely, OA; Alastruey-Izquierdo, A; Arenz, D; Chen, SCA; Dannaoui, E; Hochhegger, B; Hoenigl, M; Jensen, HE; Lagrou, K; Lewis, RE; Mellinghoff, SC; Mer, M; Pana, ZD; Seidel, D; Sheppard, DC; Wahba, R; Akova, M; Alanio, A; Al-Hatmi, AMS; Arikan-Akdagli, S; Badali, H; Ben-Ami, R; Bonifaz, A; Bretagne, S; Castagnola, E; Chayakulkeeree, M; Colombo, AL; Corzo-León, DE; Drgona, L; Groll, AH; Guinea, J; Heussel, CP; Ibrahim, AS; Kanj, SS; Klimko, N; Lackner, M; Lamoth, F; Lanternier, F; Lass-Floerl, C; Lee, DG; Lehrnbecher, T; Lmimouni, BE; Mares, M; Maschmeyer, G; Meis, JF; Meletiadis, J; Morrissey, CO; Nucci, M; Oladele, R; Pagano, L; Pasqualotto, A; Patel, A; Racil, Z; Richardson, M; Roilides, E; Ruhnke, M; Seyedmousavi, S; Sidharthan, N; Singh, N; Sinko, J; Skiada, A; Slavin, M; Soman, R; Spellberg, B; Steinbach, W; Tan, BH; Ullmann, AJ; Vehreschild, JJ; Vehreschild, MJGT; Walsh, TJ; White, PL; Wiederhold, NP; Zaoutis, T; Chakrabarti, A; Mucormycosis ECMM MSG Global Guideline Writing Group
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.
LANCET INFECT DIS. 2019; 19(12): e405-e421-e405-e421.
Doi: 10.1016/S1473-3099(19)30312-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jenks, JD; Mehta, SR; Hoenigl, M
Broad spectrum triazoles for invasive mould infections in adults: Which drug and when?
Med Mycol. 2019; 57(Supplement_2):S168-S178
Doi: 10.1093/mmy/myy052
Web of Science
PubMed
FullText
FullText_MUG
Jenks, JD; Spiess, B; Buchheidt, D; Hoenigl, M
(New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples.
CURR FUNGAL INFECT R. 2019; 13(3): 129-136.
Doi: 10.1007/s12281-019-00342-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pea, F; Krause, R; Müller, C; Hennart, B; Richardson, M; Meinitzer, A; Wiesen, MHJ; Wiktorowicz, T; Spickermann, J; Henriksen, AS
Inter-laboratory analysis of Isavuconazole plasma concentration assays among European laboratories.
Ther Drug Monit. 2019;
Doi: 10.1097/FTD.0000000000000632
PubMed
FullText
FullText_MUG
Pea, F; Krause, R; Müller, C; Hennart, B; Richardson, M; Meinitzer, A; Wiesen, MHJ; Wiktorowicz, T; Spickermann, J; Henriksen, AS
Interlaboratory Analysis of Isavuconazole Plasma Concentration Assays Among European Laboratories.
Ther Drug Monit. 2019; 41(5):657-664
Doi: 10.1097/FTD.0000000000000632
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Alastruey-Izquierdo, A; Cadranel, J; Flick, H; Godet, C; Hennequin, C; Hoenigl, M; Kosmidis, C; Lange, C; Munteanu, O; Page, I; Salzer, HJF; on behalf of CPAnet
Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives.
Respiration. 2018; 96(2):159-170
Doi: 10.1159/000489474
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hoenigl, M; Prattes, J; Neumeister, P; Wölfler, A; Krause, R
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Mycoses. 2018; 61(3):201-205
Doi: 10.1111/myc.12727
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jenks, JD; Hoenigl, M
Treatment of Aspergillosis.
J Fungi (Basel). 2018; 4(3):
Doi: 10.3390/jof4030098
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jenks, JD; Salzer, HJ; Prattes, J; Krause, R; Buchheidt, D; Hoenigl, M
Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
Drug Des Devel Ther. 2018; 12(3):1033-1044
Doi: 10.2147/DDDT.S145545
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG